Adherence to Disease-Modifying Drugs Lowers Chronic Opioid Use in Patients with Inflammatory Conditions
A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.
Read More
 
ADVERTISEMENT
 
Claim Analysis by Specialty Pharmacist Saves Health Plan $2.7 Million, Study Finds
A new study highlights the role a qualified specialty pharmacist can play in driving down costs across a health plan.
Read More